This
page
is
part
of
the
FHIR
Specification
(v3.0.2:
(v4.0.1:
R4
-
Mixed
Normative
and
STU
3).
)
in
it's
permanent
home
(it
will
always
be
available
at
this
URL).
The
current
version
which
supercedes
this
version
is
5.0.0
.
For
a
full
list
of
available
versions,
see
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
R3
R4
R3
R2
Organization-example-good-health-care
This
is
the
narrative
for
the
resource.
See
also
the
XML
or
,
JSON
or
Turtle
format.
This
example
conforms
to
the
profile
Organization
.
Other
examples
that
reference
this
example:
Composition/Example
Consent/Consent-Not-Author
Consent/Consent-Not-Org
Composition/Example
-
mixed
Contract/PCD-notAuthor
Contract/PCD-notOrg
Device/Feeding
tube
DeviceRequest/insulinpump
MedicationDispense/Oral
Chemo
MedicationDispense/IV
Antibiotic
MedicationDispense/SC
Injection
MedicationDispense/PRN
dose
with
condition
MedicationDispense/IV
antibiotic
MedicationDispense/Tapering
Dose
MedicationDispense/IV
Chemo
MedicationDispense/Oral
Chemo
MedicationDispense/Eye
drops
MedicationDispense/Oral
Drops
MedicationDispense/As
Needed
with
condition
MedicationDispense/Suppository
MedicationDispense/OTC
MedicationDispense/KCL
admixture
MedicationDispense/IV
MedicationDispense/Oral
MedicationDispense/Insulin
MedicationDispense/IV
Chemo
MedicationDispense/Oral
MedicationDispense/Mutliple
dosage
lines
MedicationDispense/TPN
Solution
MedicationDispense/As
Needed
with
condition
MedicationDispense/Oral
suspension
MedicationDispense/Topical
Ointment
MedicationDispense/Patch
MedicationDispense/Antibiotic
MedicationDispense/Inhaler
MedicationDispense/Inhaler
MedicationDispense/Compound
MedicationDispense/Warfarin
MedicationDispense/Warfarin
Patient/x-cda
Task/In
Progress
Lipid
Panel
Task
1
Task/in
Progress
Lipid
Panel
Task
2
Task/Completed
Lipid
Panel
Task
Usage
note:
every
effort
has
been
made
to
ensure
that
the
examples
are
correct
and
useful,
but
they
are
not
a
normative
part
of
the
specification.